Abstract
Congenital heart disease is the most common congenital disorder in newborns. Advances in cardiovascular medicine and surgery have enabled most patients to reach adulthood. Unfortunately, prolonged survival has been achieved at a cost, as many patients suffer late complications, of which heart failure and arrhythmias are the most prominent. Accordingly, these patients need frequent follow-up by physicians with specific knowledge in the field of congenital heart disease. However, planning of care for this population is difficult, because the number of patients currently living with congenital heart disease is difficult to measure. Birth prevalence estimates vary widely according to different studies, and survival rates have not been well recorded. Consequently, the prevalence of congenital heart disease is unclear, with estimates exceeding the number of patients currently seen in cardiology clinics. New developments continue to influence the size of the population of patients with congenital heart disease. Prenatal screening has led to increased rates of termination of pregnancy. Improved management of complications has changed the time and mode of death caused by congenital heart disease. Several genetic and environmental factors have been shown to be involved in the etiology of congenital heart disease, although this knowledge has not yet led to the implementation of preventative measures. In this Review, we give an overview of the etiology, birth prevalence, current prevalence, mortality, and complications of congenital heart disease.
Key Points
-
The etiology of most forms of congenital heart disease is incompletely understood
-
Genetic and environmental factors probably interact in the etiology of most nonsyndromal forms of congenital heart disease
-
Epidemiological studies in congenital heart disease are hampered by diverging definitions, classifications, and methodology
-
Birth prevalence estimates vary widely according to different studies, but this measure seems to be declining overall
-
The prevalence of congenital heart disease is increasing
-
The reported prevalence does not reflect the number of patients currently receiving care for congenital heart disease
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tennant, P. W. G., Pearce, M. S., Bythell, M. & Rankin, J. 20-year survival of children born with congenital anomalies: a population-based study. Lancet 375, 649–656 (2010).
Dastgiri, S., Stone, D. H., Le-Ha, C. & Gilmour, W. H. Prevalence and secular trend of congenital anomalies in Glasgow, UK. Arch. Dis. Child 86, 257–263 (2002).
Samánek, M. Children with congenital heart disease: probability of natural survival. Pediatr. Cardiol. 13, 152–158 (1992).
Warnes, C. A. The adult with congenital heart disease: born to be bad? J. Am. Coll. Cardiol. 46, 1–8 (2005).
Mitchell, S. C., Korones, S. B. & Berendes, H. W. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation 43, 323–332 (1971).
Warnes, C. A. et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 52, e1–e121 (2008).
Connelly, M. S. et al. Canadian Consensus Conference on Adult Congenital Heart Disease 1996. Can. J. Cardiol. 14, 395–452 (1998).
Warnes, C. A. et al. Task force 1: the changing profile of congenital heart disease in adult life. J. Am. Coll. Cardiol. 37, 1170–1175 (2001).
Nora, J., Berg, K. & Nora, A. Cardiovascular Diseases. Genetics, Epidemiology and Prevention. (Oxford University Press, New York, 1991).
Vis, J. C. et al. Down syndrome: a cardiovascular perspective. J. Intellect. Disabil. Res. 53, 419–425 (2009).
van Engelen, K. et al. 22q11.2 Deletion Syndrome is under-recognized in adult patients with tetralogy of Fallot and pulmonary atresia. Heart 96, 621–624 (2010).
Joziasse, I. C. et al. Genes in congenital heart disease: atrioventricular valve formation. Basic Res. Cardiol. 103, 216–227 (2008).
Botto, L. D. & Correa, A. Decreasing the burden of congenital heart anomalies: an epidemiologic evaluation of risk factors and survival. Prog. Ped. Cardiol. 18, 111–121 (2003).
Kuciene, R. & Dulskiene, V. Selected environmental risk factors and congenital heart defects. Medicina (Kaunas) 44, 827–832 (2008).
Jenkins, K. et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115, 2995–3014 (2007).
Czeizel, A. E. Periconceptional folic acid containing multivitamin supplementation. Eur. J. Obstet. Gynecol. Reprod. Biol. 78, 151–161 (1998).
Goh, Y. I., Bollano, E., Einarson, T. R. & Koren, G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J. Obstet. Gynaecol. Can. 28, 680–689 (2006).
Nora, J. J. Multifactorial inheritance hypothesis for the etiology of congenital heart diseases. The genetic-environmental interaction. Circulation 38, 604–617 (1968).
Smith, K. A. et al. Dominant-negative ALK2 allele associates with congenital heart defects. Circulation 119, 3062–3069 (2009).
Joziasse, I. C. et al. A duplication including GATA4 does not co-segregate with congenital heart defects. Am. J. Med. Genet. A 149A, 1062–1066 (2009).
Burn, J. et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 351, 311–316 (1998).
van Driel, L. M. et al. Eight-fold increased risk for congenital heart defects in children carrying the nicotinamide N-methyltransferase polymorphism and exposed to medicines and low nicotinamide. Eur. Heart J. 29, 1424–1431 (2008).
Verkleij-Hagoort, A. C. et al. Genetic and lifestyle factors related to the periconception vitamin B12 status and congenital heart defects: a Dutch case-control study. Mol. Genet. Metab. 94, 112–119 (2008).
van Beynum, I. M. et al. Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects. Clin. Chem. Lab. Med. 46, 1369–1375 (2008).
Øyen, N. et al. Recurrence of congenital heart defects in families. Circulation 120, 295–301 (2009).
Calcagni, G., Digilio, M. C., Sarkozy, A., Dallapiccola, B. & Marino, B. Familial recurrence of congenital heart disease: an overview and review of the literature. Eur. J. Pediatr. 166, 111–116 (2007).
Loffredo, C. A. et al. Prevalence of congenital cardiovascular malformations among relatives of infants with hypoplastic left heart, coarctation of the aorta, and d-transposition of the great arteries. Am. J. Med. Genet. A 124A, 225–230 (2004).
Gill, H. K., Splitt, M., Sharland, G. K. & Simpson, J. M. Patterns of recurrence of congenital heart disease: an analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J. Am. Coll. Cardiol. 42, 923–929 (2003).
Driscoll, D. J. et al. Occurrence risk for congenital heart defects in relatives of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 87, I114–I120 (1993).
Wessels, M. W. & Willems, P. J. Genetic factors in non-syndromic congenital heart malformations. Clin. Genet 78, 103–123 (2010).
Schott, J. J. et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5 Science 281, 108–111 (1998).
Garg, V. et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424, 443–447 (2003).
Mason, C. A., Kirby, R. S., Sever, L. E. & Langlois, P. H. Prevalence is the preferred measure of frequency of birth defects. Birth Defects Res. Part A Clin. Mol. Teratol. 73, 690–692 (2005).
Hoffman, J. I. & Kaplan, S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39, 1890–1900 (2002).
Bernier, P. L., Stefanescu, A., Samoukovic, G. & Tchervenkov, C. I. The challenge of congenital heart disease worldwide: epidemiologic and demographic facts. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 13, 26–34 (2010).
Wren, C. & O'Sullivan, J. J. Survival with congenital heart disease and need for follow up in adult life. Heart 85, 438–443 (2001).
Wren, C., Reinhardt, Z. & Khawaja, K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch. Dis. Child. Fetal Neonatal Ed. 93, F33–F35 (2008).
Pradat, P., Francannet, C., Harris, J. A. & Robert, E. The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr. Cardiol. 24, 195–221 (2003).
Botto, L. D., Correa, A. & Erickson, J. D. Racial and temporal variations in the prevalence of heart defects. Pediatrics 107, E32 (2001).
EUROCAT. Special Report: Congenital Heart Defects in Europe, 2000–2005 EUROCAT [online], (2009).
Calzolari, E. et al. Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy). Eur. J. Epidemiol. 18, 773–780 (2003).
Stephensen, S. S. et al. Congenital cardiac malformations in Iceland from 1990 through 1999. Cardiol. Young 14, 396–401 (2004).
Wu, M. H. et al. Prevalence of congenital heart disease at live birth in Taiwan. J. Pediatr. 156, 782–785 (2010).
Robida, A., Folger, G. M. & Hajar, H. A. Incidence of congenital heart disease in Qatari children. Int. J. Cardiol. 60, 19–22 (1997).
Roguin, N. et al. High prevalence of muscular ventricular septal defect in neonates. J. Am. Coll. Cardiol. 26, 1545–1548 (1995).
Hiraishi, S. et al. Incidence and natural course of trabecular ventricular septal defect: two-dimensional echocardiography and color Doppler flow imaging study. J. Pediatr. 120, 409–415 (1992).
Nembhard, W. N., Wang, T., Loscalzo, M. L. & Salemi, J. L. Variation in the prevalence of congenital heart defects by maternal race/ethnicity and infant sex. J. Pediatr. 156, 259–264 (2010).
Somerville, J. The Denolin Lecture: The woman with congenital heart disease. Eur. Heart J. 19, 1766–1775 (1998).
Engelfriet, P. & Mulder, B. J. Gender differences in adult congenital heart disease. Neth. Heart J. 17, 414–417 (2009).
Siddique, J., Lauderdale, D. S., VanderWeele, T. J. & Lantos, J. D. Trends in prenatal ultrasound use in the United States: 1995 to 2006. Med. Care 47, 1129–1135 (2009).
Tomek, V., Marek, J., Jicínská, H. & Skovránek, J. Fetal cardiology in the Czech Republic: current management of prenatally diagnosed congenital heart diseases and arrhythmias. Physiol. Res. 58 (Suppl. 2), S159–S166 (2009).
Tegnander, E., Williams, W., Johansen, O. J., Blaas, H. G. & Eik-Nes, S. H. Prenatal detection of heart defects in a non-selected population of 30,149 fetuses—detection rates and outcome. Ultrasound Obstet. Gynecol. 27, 252–265 (2006).
Paladini, D. et al. Prenatal diagnosis of congenital heart disease in the Naples area during the years 1994–1999—the experience of a joint fetal-pediatric cardiology unit. Prenat. Diagn. 22, 545–552 (2002).
Fesslova, V., Nava, S. & Villa, L. Evolution and long term outcome in cases with fetal diagnosis of congenital heart disease: Italian multicenter study. Fetal Cardiology Study Group of the Italian Society of Pediatric Cardiology. Heart 82, 594–599 (1999).
Bull, C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Pediatric Cardiac Association. Lancet 354, 1242–1247 (1999).
Germanakis, I. & Sifakis, S. The impact of fetal echocardiography on the prevalence of liveborn congenital heart disease. Pediatr. Cardiol. 27, 465–472 (2006).
Dolk, H., Loane, M. A., Abramsky, L., de Walle, H. & Garne, E. Birth prevalence of congenital heart disease. Epidemiology 21, 275–277 (2010).
EUROCAT Northern Netherlands. Prevalence of congenital malformations in the Northern Netherlands, 1981–2007 University of Groningen [online], (2009).
Øyen, N. et al. National time trends in congenital heart defects, Denmark, 1977–2005. Am. Heart J. 157, 467–473e1 (2009).
Ionescu-Ittu, R., Marelli, A. J., Mackie, A. S. & Pilote, L. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ 338, b1673 (2009).
EUROCAT. Prevention of Neural Tube Defects by Periconceptional Folic Acid Supplementation in Europe. EUROCAT [online], (2009).
Nieminen, H. P., Jokinen, E. V. & Sairanen, H. I. Late results of pediatric cardiac surgery in Finland: a population-based study with 96% follow-up. Circulation 104, 570–575 (2001).
Morris, C. D. & Menashe, V. D. 25-year mortality after surgical repair of congenital heart defect in childhood. A population-based cohort study. JAMA 266, 3447–3452 (1991).
Marelli, A. J., Mackie, A. S., Ionescu-Ittu, R., Rahme, E. & Pilote, L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 115, 163–172 (2007).
Winter, M. M., Mulder, B. J. & van der Velde, E. T. Letter by Winter. et al. regarding article, “Children and adults with congenital heart disease lost to follow-up: who and when?”. Circulation 121, e252 (2010).
Mackie, A. S. et al. Children and adults with congenital heart disease lost to follow-up: who and when? Circulation 120, 302–309 (2009).
Moons, P. et al. Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey. Eur. Heart J. 27, 1324–1330 (2006).
van der Velde, E. T. et al. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur. J. Epidemiol. 20, 549–557 (2005).
Meberg, A., Otterstad, J. E., Frøland, G., Lindberg, H. & Sørland, S. J. Outcome of congenital heart defects—a population-based study. Acta Pediatr. 89, 1344–1351 (2000).
Shiina, Y. et al. Prevalence of adult patients with congenital heart disease in Japan. Int. J. Cardiol. doi: 10.1016/j.ijcard.2009.05.032.
Verheugt, C. L. et al. The emerging burden of hospital admissions of adults with congenital heart disease. Heart 96, 872–878 (2010).
Opotowsky, A. R., Siddiqi, O. K. & Webb, G. D. Trends in hospitalizations for adults with congenital heart disease in the US. J. Am. Coll. Cardiol. 54, 460–467 (2009).
Boneva, R. S. et al. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979–1997. Circulation 103, 2376–2381 (2001).
Pillutla, P., Shetty, K. D. & Foster, E. Mortality associated with adult congenital heart disease: trends in the US population from 1979 to 2005. Am. Heart J. 158, 874–879 (2009).
Billett, J., Majeed, A., Gatzoulis, M. & Cowie, M. Trends in hospital admissions, in-hospital case fatality and population mortality from congenital heart disease in England, 1994 to 2004. Heart 94, 342–348 (2008).
Oechslin, E. N., Harrison, D. A., Connelly, M. S., Webb, G. D. & Siu, S. C. Mode of death in adults with congenital heart disease. Am. J. Cardiol. 86, 1111–1116 (2000).
Verheugt, C. L. et al. Mortality in adult congenital heart disease. Eur. Heart J. 31, 1220–1229 (2010).
Zomer, A. C. et al. Mortality in adult congenital heart disease: are national registries reliable for cause of death? Int. J. Cardiol. doi: 10.1016/j.ijcard.2010.07.018.
Verheugt, C. L. et al. Gender and outcome in adult congenital heart disease. Circulation 118, 26–32 (2008).
Lok, S. I. et al. Recurrence of cerebrovascular events in young adults with a secundum atrial septal defect. Int. J. Cardiol. 142, 44–49 (2010).
Li, W. & Somerville, J. Infective endocarditis in the grown-up congenital heart (GUCH) population. Eur. Heart J. 19, 166–173 (1998).
Morris, C. D., Reller, M. D. & Menashe, V. D. Thirty-year incidence of infective endocarditis after surgery for congenital heart defect. JAMA 279, 599–603 (1998).
Dodo, H. & Child, J. S. Infective endocarditis in congenital heart disease. Cardiol. Clin. 14, 383–392 (1996).
Fisher, M. C. Changing risk factors for pediatric infective endocarditis. Curr. Infect. Dis. Rep. 3, 333–336 (2001).
Gersony, W. M. et al. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 87, I121–I126 (1993).
Tleyjeh, I. et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 293, 3022–3028 (2005).
Niwa, K., Nakazawa, M., Tateno, S., Yoshinaga, M. & Terai, M. Infective endocarditis in congenital heart disease: Japanese national collaboration study. Heart 91, 795–800 (2005).
Di Fillipo, S. et al. Current patterns of infective endocarditis in congenital heart disease. Heart 92, 1490–1495 (2006).
Takeda, S., Nakanishi, T. & Nakazawa, M. A 28-year trend of infective endocarditis associated with congenital heart diseases: a single institute experience. Pediatr. Int. 47, 392–396 (2005).
Verheugt, C. L., Uiterwaal, C. S., Grobbee, D. E. & Mulder, B. J. Long-term prognosis of congenital heart defects: a systematic review. Int. J. Cardiol. 131, 25–32 (2008).
Engelfriet, P. et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur. Heart J. 26, 2325–2333 (2005).
Walsh, E. P. & Cecchin, F. Arrhythmias in adult patients with congenital heart disease. Circulation 115, 534–545 (2007).
Khairy, P. et al. Arrhythmias in adult congenital heart disease. Expert. Rev. Cardiovasc. Ther. 4, 83–95 (2006).
Silka, M. J., Hardy, B. G., Menashe, V. D. & Morris, C. D. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J. Am. Coll. Cardiol. 32, 245–251 (1998).
Sekar, R. P. Epidemiology of arrhythmias in children. Indian Pacing Electrophysiol. J. 8 (Suppl. 1), S8–S13 (2008).
Rekawek, J. et al. Risk factors for cardiac arrhythmias in children with congenital heart disease after surgical intervention in the early postoperative period. J. Thorac. Cardiovasc. Surg. 133, 900–904 (2007).
Delaney, J. W., Moltedo, J. M., Dziura, J. D., Kopf, G. S. & Snyder, C. S. Early postoperative arrhythmias after pediatric cardiac surgery. J. Thorac. Cardiovasc. Surg. 131, 1296–1300 (2006).
Hoffman, T. M. et al. The incidence of arrhythmias in a pediatric cardiac intensive care unit. Pediatr. Cardiol. 23, 598–604 (2002).
Mildh, L. et al. Junctional ectopic tachycardia after surgery for congenital heart disease: incidence, risk factors and outcome. Eur. J. Cardiothorac. Surg. doi: 10.1016/j.ejcts.2010.04.002.
Gelatt, M. et al. Risk factors for atrial tachyarrhythmias after the Fontan operation. J. Am. Coll. Cardiol. 24, 1735–1741 (1994).
van den Bosch, A. E. et al. Long-term outcome and quality of life in adult patients after the Fontan operation. Am. J. Cardiol. 93, 1141–1145 (2004).
Khairy, P. et al. for the AARCC. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation 122, 868–875 (2010).
Gelatt, M. et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J. Am. Coll. Cardiol. 29, 194–201 (1997).
Rhodes, L. A. et al. Arrhythmias and intracardiac conduction after the arterial switch operation. J. Thorac. Cardiovasc. Surg. 109, 303–310 (1995).
Cecchin, F., Johnsrude, C. L., Perry, J. C. & Friedman, R. A. Effect of age and surgical technique on symptomatic arrhythmias after the Fontan procedure. Am. J. Cardiol. 76, 386–391 (1995).
Srinathan, S. K. et al. Changing practice of cardiac surgery in adult patients with congenital heart disease. Heart 91, 207–212 (2005).
Giamberti, A. et al. Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations. Ann. Thorac. Surg. 88, 1284–1289 (2009).
Berdat, P. A., Immer, F., Pfammatter, J. P. & Carrel, T. Reoperations in adults with congenital heart disease: analysis of early outcome. Int. J. Cardiol. 93, 239–245 (2004).
Vida, V. L. et al. Risk of surgery for congenital heart disease in the adult: a multicentered European study. Ann. Thorac. Surg. 83, 161–168 (2007).
Oosterhof, T. et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 116, 545–551 (2007).
Voskuil, M. et al. Postsurgical course of patients with congenitally corrected transposition of the great arteries. Am. J. Cardiol. 83, 558–562 (1999).
Stellin, G., Vida, V. L., Padalino, M. A. & Rizzoli, G. Surgical outcome for congenital heart malformations in the adult age: a multicentric European study. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 7, 95–101 (2004).
Daebritz, S. H. Update in adult congenital cardiac surgery. Pediatr. Cardiol. 28, 96–104 (2007).
Vriend, J. W. et al. Predictive value of mild, residual descending aortic narrowing for blood pressure and vascular damage in patients after repair of aortic coarctation. Eur. Heart J. 26, 84–90 (2005).
Vriend, J. W. & Mulder, B. J. Late complications in patients after repair of aortic coarctation: implications for management. Int. J. Cardiol. 101, 399–406 (2005).
Padalino, M. A. et al. Midterm results of surgical intervention for congenital heart disease in adults: an Italian multicenter study. J. Thorac. Cardiovasc. Surg. 134, 106–113 (2007).
Norozi, K. et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am. J. Cardiol. 97, 1238–1243 (2006).
Winter, M. M. et al. Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure. Heart 95, 960–963 (2009).
Chaturvedi, V. & Saxena, A. Heart failure in children: clinical aspect and management. Indian J. Pediatr. 76, 195–205 (2009).
Piran, S., Veldtman, G., Siu, S., Webb, G. D. & Liu, P. P. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation 105, 1189–1194 (2002).
Tulevski, I. I. et al. Right ventricular function in congenital cardiac disease: noninvasive quantitative parameters for clinical follow-up. Cardiol. Young 13, 397–403 (2003).
Tulevski, I. I. et al. Regional and global right ventricular dysfunction in asymptomatic or minimally symptomatic patients with congenitally corrected transposition. Cardiol. Young 14, 168–173 (2004).
Winter, M. M. et al. Mechanisms for cardiac output augmentation in patients with a systemic right ventricle. Int. J. Cardiol. 143, 141–146 (2010).
Winter, M. M. et al. Evaluating the systemic right ventricle by CMR: the importance of consistent and reproducible delineation of the cavity. J. Cardiovasc. Magn. Reson. 10, 40 (2008).
Tulevski, I. I. et al. Effect of pulmonary valve regurgitation on right ventricular function in patients with chronic right ventricular pressure overload. Am. J. Cardiol. 92, 113–116 (2003).
Oosterhof, T., Tulevski, I. I., Vliegen, H. W., Spijkerboer, A. M. & Mulder, B. J. Effects of volume and/or pressure overload secondary to congenital heart disease (tetralogy of Fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels. Am. J. Cardiol. 97, 1051–1055 (2006).
Tulevski, I. I. et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 86, 27–30 (2001).
Barst, R. J. et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 43, 40S–47S (2004).
Duffels, M. G. et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int. J. Cardiol. 120, 198–204 (2007).
Vongpatanasin, W., Brickner, M. E., Hillis, L. D. & Lange, R. A. The Eisenmenger syndrome in adults. Ann. Intern. Med. 128, 745–755 (1998).
Diller, G. & Gatzoulis, M. A. Pulmonary vascular disease in adults with congenital heart disease. Circulation 115, 1039–1050 (2007).
Engelfriet, P. M. et al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart 93, 682–687 (2007).
Walsh, E. P. Interventional electrophysiology in patients with congenital heart disease. Circulation 115, 3224–3234 (2007).
Author information
Authors and Affiliations
Contributions
T. van der Bom and A. C. Zomer equally contributed to this manuscript. Both contributed to discussion of content for the article, researched data to include in the manuscript, reviewed and edited the manuscript before submission, and revised the manuscript in response to the peer-reviewers' comments. A. H. Zwinderman reviewed and edited the manuscript before submission. F. J. Meijboom, B. J. Bouma, and B. J. M. Mulder contributed to discussion of content for the article and reviewed and edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
van der Bom, T., Zomer, A., Zwinderman, A. et al. The changing epidemiology of congenital heart disease. Nat Rev Cardiol 8, 50–60 (2011). https://doi.org/10.1038/nrcardio.2010.166
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2010.166
This article is cited by
-
Association between lipid profile in early pregnancy and the risk of congenital heart disease in offspring: a prospective cohort study
Scientific Reports (2024)
-
Thymic Atrophy and Immune Dysregulation in Infants with Complex Congenital Heart Disease
Journal of Clinical Immunology (2024)
-
Risk factor analysis for adverse prognosis of the fetal ventricular septal defect (VSD)
BMC Pregnancy and Childbirth (2023)
-
Impact of maternal age and body mass index on the structure and function of the heart in newborns: a Copenhagen Baby Heart Study
BMC Medicine (2023)
-
White-Sutton syndrome and congenital heart disease: case report and literature review
BMC Pediatrics (2023)